Capacity Assessments (April/May/June)

Date of Issue: 04/01/2021 | Volume: 1 | Number: 3&4

Issue Links:Learning Objectives

Dr. Erick Cheung shares tips for assessing decisional capacity and Dr. Syed expands on this topic in her discussion of capacity evaluations of pregnant, mentally ill women. Also, we learn how to use VMAT-2 inhibitors for tardive dyskinesia.

In This Issue

Editor's Note

Note From the Editor-in-Chief

Read More
Clinical Update

Finally, Effective Treatments for Tardive Dyskinesia

Topics: Adjunct treatment | AIMS test (Assessment of Involuntary Movement) | Antipsychotics | Assent | Austedo | Deutetrabenazine | Ingrezza | Tardive dyskinesia | Tetrabenazine | Valbenazine | VMAT2 Inhibitors | Xenazine

VMAT-2 inhibitors significantly reduce the symptoms of tardive dyskinesia. We learn how to prescribe them and what side effects and drug interactions to watch for.

Read More
Expert Q&A

Decisional Capacity

Topics: Aid to capacity evaluation (ACE) | Capacity | Collaborative care | Decisional Capacity | Dispositional capacity | Medical incapacity hold | Surrogate decision-maker

Patients sometimes refuse necessary, even lifesaving, treatments. How do we know they are making informed and reasonable decisions? Dr. Cheung summarizes key points in evaluating patients’ decisional capacity.

Read More
Expert Q&A

Capacity Assessment in Pregnant Patients

Topics: Aid to capacity evaluation (ACE) | Capacity | Pregnancy | Surrogate decision-maker

Imagine working with a pregnant, mentally ill woman who refuses critical obstetric interventions. Dr. Syed walks us through the steps to determine if these patients lack decisional capacity and explains how we can arrange for surrogate decision-makers.

Read More
Research Update

Suvorexant May Prevent Delirium in Hospitalized Patients

Topics: Delirium | Geriatric Psychiatry | Suvorexant

Can suvorexant reduce the risk of delirium in elderly hospitalized patients?

Read More
Research Update

SSRIs and Intracerebral Hemorrhage Risk

Topics: Bleeding | Citalopram | Depression | Escitalopram | Fluoxetine | Geriatric | Hemorrhagic | Intra-cerebral hemorrhage | Mortality | Paroxetine | Post-stroke depression | Prozac | Serotonin Specific Reuptake Inhibitors (SSRIs) | Sertraline | SSRIs | Stroke

SSRIs help relieve post-stroke depression but increase the risk of intracerebral hemorrhage. This study gives us tips to reduce this risk.

Read More
Research Update

Can Antidepressants Prolong Survival in Cancer Patients?

Topics: Adherence | Cancer | Citalopram | Depression | Escitalopram | Fluoxetine | Mortality | Paroxetine | Prozac | Serotonin Specific Reuptake Inhibitors (SSRIs) | Sertraline | SSRIs

Antidepressant adherence is linked with increased survival among cancer patients.

Read More
Research Update

Hyperprolactinemia: Effective Treatment With Aripiprazole

Topics: Aripiprazole | Prolactin

Many antipsychotic medications produce hyperprolactinemia, leading to breast enlargement in men and missed menstrual cycles in women. A clever intervention reduces patients' prolactin levels.

Read More
CME Post-Test

CME Post-Test - Capacity Assessments, CHPR, April/May/June 2021

Topics: CME Post-Test

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits.

Read More